Consultation on a provisional agreement with GlaxoSmithKline for amended terms of listing of lamotrigine (Lamictal) on the Pharmaceutical Schedule

Medicines

Consultation Closed

PHARMAC and GlaxoSmithKline NZ Limited have entered into a provisional agreement to amend the terms of listing of lamotrigine (Lamictal) in Section B of the Pharmaceutical Schedule, and to list Lamictal in Section H of the Pharmaceutical Schedule.

Key aspects of this proposal are as follows:

  • Lamotrigine (Lamictal) dispersible tablets would be listed in Section B of the Pharmaceutical Schedule at the following prices and subsidies with effect from 1 July 2007 (ex-manufacturer, excluding GST):
    Pharmaceutical Brand Form Strength Pack size Current price & subsidy New price & subsidy
    Lamotrigine Lamictal Tablet 2 mg 30 Not listed $6.74
    Lamotrigine Lamictal Tablet 5 mg 30 $9.64 $9.64
    Lamotrigine Lamictal Tablet 25 mg 56 $51.07 $29.09
    Lamotrigine Lamictal Tablet 50 mg 56 $86.82 $47.89
    Lamotrigine Lamictal Tablet 100 mg 56 $149.81 $79.16
  • Lamictal would be listed in Section B of the Pharmaceutical Schedule with no Special Authority.
  • Lamictal tablets dispensed in the community would be subject to a confidential rebate, the effect of which would be to reduce the effective cost of Lamictal tablets to be in line with the price of generic lamotrigine tablets (listed on 1 February 2007).
  • Lamictal dispersible tablets would be listed in Part II of Section H of the Pharmaceutical Schedule from 1 July 2007 at the following prices (ex-manufacturer, excluding GST):
    Pharmaceutical Brand Form Strength Pack Size Price
    Lamotrigine Lamictal Tablet 2 mg 30 $6.74
    Lamotrigine Lamictal Tablet 5 mg 30 $9.64
    Lamotrigine Lamictal Tablet 25 mg 56 $29.09
    Lamotrigine Lamictal Tablet 50 mg 56 $47.89
    Lamotrigine Lamictal Tablet 100 mg 56 $79.16
  • Lamictal would have protection from delisting and subsidy reduction until 1 February 2010.
  • A new 200 mg Lamictal tablet may be listed in Sections B and H of the Pharmaceutical Schedule at a later date, at the following price and subsidy:
    Pharmaceutical Brand Form Strength Pack Size Price
    Lamotrigine Lamictal Tablet 200 mg 56 $132.35
  • Lamictal 5 mg tablet may be changed from a 30 tablet pack to a 56 tablet pack at a later date as follows:
    Pharmaceutical Brand Form Strength Pack Size Price
    Lamotrigine Lamictal Tablet 5 mg 56 $15.00

If you wish to make comments for the PHARMAC Board to consider when making its decision on whether to accept this proposal, please forward them to PHARMAC by 5:00 pm, 18 May 2007. All comments submitted by this date will be considered.